← What we do Capability 01

Capability 01 · International Growth Advisory

International Growth Advisory

Turning international ambition into clear market priorities, operating choices and leadership alignment.

When this matters

Many Chinese MedTech companies already have some overseas sales, but not a shared view of which markets matter most, what growth model is realistic, or what decisions should guide the next stage of investment. This capability matters when leadership wants strategic clarity before committing further resources to international growth.

Key questions we help clarify

  • Which international markets genuinely deserve priority and investment
  • What growth model is realistic given the product, the organisation and its resources
  • Where the company can build durable traction rather than one-off sales
  • What leadership needs to align on before the next stage of investment
  • How international ambition becomes a clear strategic direction

How this connects to international growth capability

Clear strategic direction is the foundation the other capabilities build on. When leadership agrees on where to grow and why, market entry, execution and partnership work all become more focused and far less wasteful.

What this is not

  • Not a generic market-sizing report
  • Not a list of countries to pursue without a strategy
  • Not a substitute for leadership judgment; we help structure the decision, and the company makes it

START WITH A FOCUSED CONVERSATION

Not sure where to begin? We can help you clarify the right starting point.

Talk to our team →